A review of glucagon‐like peptide‐1 receptor agonists and their effects on lowering postprandial plasma glucose and cardiovascular outcomes in the treatment of type 2 diabetes mellitus

Type 2 diabetes mellitus (T2DM) is an independent risk factor for cardiovascular (CV) comorbidities, with CV disease being the most common cause of death in adults with T2DM. Although glucocentric therapies may improve glycaemic control (as determined by glycated haemoglobin levels), evidence sugges...

Descripción completa

Detalles Bibliográficos
Autores principales: Owens, David R., Monnier, Louis, Hanefeld, Markolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2017
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697665/
https://www.ncbi.nlm.nih.gov/pubmed/28474401
http://dx.doi.org/10.1111/dom.12998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697665/
https://www.ncbi.nlm.nih.gov/pubmed/28474401
http://dx.doi.org/10.1111/dom.12998

Ejemplares similares